연구성과로 돌아가기

2023 연구성과별 연구자 정보 (734 / 2675)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, Hye Lim Lee, HL 22 Korea Univ, Dept Neurol, Coll Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Lee, Hye Lim Lee, HL 22 Korea Univ, Coll Med, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Choi, Kyomin Choi, K 23 Konkuk Univ, Dept Neurol, Sch Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Choi, Kyomin Choi, K 23 Konkuk Univ, Sch Med, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Huh, So-Young Huh, SY 24 Kosin Univ, Dept Neurol, Coll Med, Pusan, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Huh, So-Young Huh, SY 24 Kosin Univ, Coll Med, Dept Neurol, Busan, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Jang, Myoung-jin Jang, MJ 25 Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Jang, Myoung-jin Jang, MJ 25 Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Min, Ju-Hong Min, JH 26 Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Min, Ju-Hong Min, JH 26 Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Kim, Byoung Joon Kim, BJ 27 교신저자 Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Kim, Byoung Joon Kim, BJ 27 Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Kim, Sung-Min Kim, SM 28 교신저자 Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Kim, Sung-Min Kim, SM 28 교신저자 Seoul Natl Univ, Dept Neurol, Coll Med, Seoul 03080, South Korea bjkim@skku.edu;sueh916@gmail.com;
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum Kim, Sung Min Kim, SM 28 Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea
페이지 이동: